Ptc Therapeutics (PTCT) Change in Cash (2012 - 2026)

Ptc Therapeutics' Change in Cash history runs 15 years deep, the most recent figure standing at -$147.9 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 121.11% year-over-year to -$147.9 million in Q1 2026; TTM through Mar 2026 was -$645.4 million, a 169.31% decrease from a year earlier, with the FY2025 full-year figure at $203.0 million, up 9.72% from the prior year.
• Change in Cash declined to -$147.9 million in Q1 2026 per PTCT's latest filing, from $312.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $700.5 million in Q1 2025 and bottomed at -$462.8 million in Q2 2025.
• The 5-year median for Change in Cash is -$43.1 million (2023), against an average of $38.4 million.
• Across the five-year window, Change in Cash soared 175514.0% in 2022 and plunged 545.34% in 2025, its largest moves.
• Year by year, Change in Cash stood at $175.4 million in 2022, then jumped by 144.49% to $428.9 million in 2023, then plunged by 40.42% to $255.5 million in 2024, then gained by 22.11% to $312.0 million in 2025, then sank by 147.4% to -$147.9 million in 2026.
• Per Business Quant, the three latest PTCT Change in Cash figures stand at -$147.9 million (Q1 2026), $312.0 million (Q4 2025), and -$346.8 million (Q3 2025).